Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
ISATUXIMAB
Sarclisa
Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia
ACT15378ISAKIDSNCT03860844Tabulated Results
ISATUXIMAB
Sarclisa
Warm autoimmune hemolytic anemia
ACT16832NANCT04661033Tabulated Results
ISATUXIMAB
Sarclisa
Plasma cell myeloma
EFC14335ICARIA-MMNCT02990338Tabulated results
ISATUXIMAB
Sarclisa
Plasma Cell Myeloma
EFC15246IKEMANCT03275285Tabulated results
ISATUXIMAB
Sarclisa
Plasma cell myeloma
TCD11863NANCT01749969PublicationSummary
ISATUXIMAB
Not marketed
Plasma Cell Myeloma
TCD14079PomdeSARNCT02283775Publication reference
ISATUXIMAB
Sarclisa
Plasma Cell Myeloma
TCD14906NANCT03194867SummaryTabulated Results
ISATUXIMAB
Sarclisa
Hematological malignancy
TED10893NANCT01084252Summary
ISATUXIMAB
Sarclisa
Multiple Myeloma
TED14095IslandsNCT02812706Tabulated Results
ISATUXIMAB
Sarclisa®
Plasma Cell Myeloma
TED14154NANCT02514668Publication reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted